ARCHIVES

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

NCI Backed Studies Indicate Overweight Not Much Of a Cancer Risk Factor

June 19, 1987

GM Downsizes “Nobel Prize” For Cancer; Bristol Ends Medical Research Grants and Awards Program.

June 23, 2006

NCI Initiatives: Advisors Approves AIDS, Minority Training Programs

December 13, 1996

A tissue bank to break the bank? NCI, National Dialogue on Cancer plan expensive resource.

August 8, 2003

NCI to set separate payline for R01s over $700,000.

February 13, 2004

DCPC Board Approves $40 Million In New Concepts, Including Three In Breast Cancer, One In Melanoma

October 12, 1984